Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-27

FDA Approved: QUILLIVANT XR — Original Application (NextWave Pharmaceuticals, Inc)

View source ↗

Summary

The FDA approved QUILLIVANT XR (methylphenidate hydrochloride) from NextWave Pharmaceuticals in an Original Application, indicating approval for attention-defic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

ORIG AP for QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE)